The Figure Two (Figure [1](#F1){ref-type="fig"} here), X-axis description of each sample was inverted in the original publication \[[@B1]\].

![**The mRNA expression profiles of differentially expressed genes.** Both the upregulated (**A**) and downregulated (**B**) genes were selected randomly. Gel images on top show the polymerase chain reaction (PCR) product bands stained with ethidium bromide; the band intensities are also presented graphically below for clarity. Lane numbers 1 to 8 indicate sham control (lanes 1, 2, 5, and 6) and permanent middle cerebral artery occlusion (PMCAO) treatment (lanes 3, 4, 7, and 8), respectively. P indicates pituitary adenylate cyclase-activating polypeptide (PACAP) treatment; C is the control (minus PACAP). *GAPDH* and *beta-actin* genes were used a positive control (**C**). Semi-quantitative RT-PCR was performed as described in Methods, and the specific 3'-UTR primers are detailed in Additional file 2: Table S2.](1742-2094-10-18-1){#F1}

With reference to corrected Figure Two (Figure [1](#F1){ref-type="fig"} here), we have the following revised text.

On Page 9, left column: lines 19-24 should read as -

"Similarly, *Il6*, *S100a5*, *Il22*, *Il1b*, *Igf1*, and *Ccl2* were highly expressed at 6 h in the PACAP-treated ischemic brain, whereas their expression level decreased at 24 h compared to the PMCAO effect alone (Figure Two (Figure [1](#F1){ref-type="fig"} here)). *Fgf21*, *Pitpnc1*, and *Epha3* genes showed an increase in expression at 24 h over PMCAO alone (Figure Two (Figure [1](#F1){ref-type="fig"} here))."

On Page 11, right column: lines 16-19 should read as -

"In the ischemic hemisphere at 24 h, the PACAP plus PMCAO expression level of *Il6* was also reduced compared to the PMCAO plus saline control."

We regret any inconvenience that this inaccuracy in Figure Two (Figure [1](#F1){ref-type="fig"} here) and therein the figure legend, which could not be properly corrected at the proof stage, in the originally published manuscript might have caused.
